Burton et al., 1985 - Google Patents
Atrioventricular block following overdose of decongestant cold medicationBurton et al., 1985
- Document ID
- 10548247571605869393
- Author
- Burton B
- Rice M
- Schmertzler L
- Publication year
- Publication venue
- The Journal of Emergency Medicine
External Links
Snippet
A 24-year-old man developed high-degree atrioventricular (AV) block with a pulse rate of 40 beats per minute and hypertension following an overdose of a combination decongestant cold medication that contained phenylpropanolamine, phenylephrine, chlorpheniramine …
- 239000003814 drug 0 title abstract description 15
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/44—Elemental carbon, e.g. charcoal, carbon black
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Salerno et al. | Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutter | |
| Lopez et al. | QT prolongation and torsades de pointes after administration of trimethoprim-sulfamethoxazole | |
| Finkelstein et al. | Antidotal therapy of severe acute organophosphate poisoning: a multihospital study | |
| Wang et al. | QT interval prolongation and pleomorphic ventricular tachyarrhythmia (Torsade de pointes') in organophosphate poisoning: report of a case | |
| Lidell et al. | Comparative efficacy of oral sotalol and procainamide in patients with chronic ventricular arrhythmias: a multicenter study | |
| Goldman et al. | Sodium bicarbonate to correct widened QRS in a case of flecainide overdose | |
| Steckler | Lithium-and Carbamazepine-Associated: Sinus Node Dysfunction: Nine-Year Experience: in a Psychiatric Hospital | |
| Burton et al. | Atrioventricular block following overdose of decongestant cold medication | |
| Stearns et al. | Value and hazards of intravenous procaine amide (Pronestyl) therapy | |
| Bigger Jr | The interaction of mexiletine with other cardiovascular drugs | |
| Mehta et al. | Mexiletine, a new antiarrhythmic agent, for treatment of premature ventricular complexes | |
| Shahar et al. | Extrapyramidal parkinsonism complicating acute organophosphate insecticide poisoning | |
| Flecainide Ventricular Tachycardia Study Group | Treatment of resistant ventricular tachycardia with flecainide acetate | |
| Stavens et al. | Aggravation of electrically provoked ventricular tachycardia during treatment with propafenone | |
| Greenwood et al. | Sinoatrial heart block with Wenckebach phenomenon | |
| Aber et al. | Complete heart block treated with corticotrophin and corticosteroid | |
| Cocco et al. | Antiarrhythmic use of cibenzoline, a new class 1 antiarrhythmic agent with class 3 and 4 properties, in patients with recurrent ventricular tachycardia | |
| Kulling et al. | ?-adrenoceptor Blocker Intoxication: Epidemiological Data. Prenalterol as an Alternative in the Treatment of Cardiac Dysfunction | |
| Rothbart et al. | Clinical electrophysiology, efficacy and safety of chronic oral cibenzoline therapy in refractory ventricular tachycardia | |
| Manyari-Ortega et al. | Lidocaine-induced cardiac asystole | |
| KR0136787B1 (en) | Long lasting composition of propafenone and quinidine for treatment of cardiac conditions | |
| Olson et al. | Prognostic implications of complicated ventricular arrhythmias early after hospital discharge in acute myocardial infarction: a serial ambulatory electrocardiography study | |
| Kerin et al. | Mexiletine: long-term efficacy and side effects in patients with chronic drug-resistant potentially lethal ventricular arrhythmias | |
| Ramhamadany et al. | Dysarthria and visual hallucinations due to flecainide toxicity | |
| STERN | Paroxysmal ventricular fibrillation in the absence of other disease |